Simplex Trading’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.7K | Sell |
1,000
-500
| -33% | -$11.8K | ﹤0.01% | 6821 |
|
|
2026
Q1 | $32.4K | Sell |
1,500
-600
| -29% | -$11.1K | ﹤0.01% | 6308 |
|
|
2025
Q4 | $28.8K | Buy |
2,100
+1,800
| +600% | +$28K | ﹤0.01% | 6145 |
|
|
2025
Q3 | $5K | Sell |
300
-1,500
| -83% | -$23.7K | ﹤0.01% | 8336 |
|
|
2025
Q2 | $27K | Sell |
1,800
-900
| -33% | -$14.9K | ﹤0.01% | 6502 |
|
|
2025
Q1 | $43K | Sell |
2,700
-800
| -23% | -$14.9K | ﹤0.01% | 5927 |
|
|
2024
Q4 | $60K | Sell |
3,500
-7,300
| -68% | -$129K | ﹤0.01% | 5688 |
|
|
2024
Q3 | $189K | Sell |
10,800
-5,600
| -34% | -$95.5K | ﹤0.01% | 4571 |
|
|
2024
Q2 | $183K | Sell |
16,400
-14,800
| -47% | -$139K | ﹤0.01% | 4744 |
|
|
2024
Q1 | $271K | Buy |
31,200
+2,700
| +9% | +$24.8K | ﹤0.01% | 4521 |
|
|
2023
Q4 | $348K | Sell |
28,500
-5,800
| -17% | -$40.2K | ﹤0.01% | 4071 |
|
|
2023
Q3 | $138K | Buy |
34,300
+31,400
| +1,083% | +$195K | ﹤0.01% | 4762 |
|
|
2023
Q2 | $20K | Sell |
2,900
-97,000
| -97% | -$620K | ﹤0.01% | 6783 |
|
|
2023
Q1 | $335K | Sell |
99,900
-23,500
| -19% | -$70.9K | ﹤0.01% | 3698 |
|
|
2022
Q4 | $341K | Buy |
123,400
+83,200
| +207% | +$187K | ﹤0.01% | 3589 |
|
|
2022
Q3 | $92K | Buy |
40,200
+38,200
| +1,910% | +$62K | ﹤0.01% | 5645 |
|
|
2022
Q2 | $3K | Sell |
2,000
-800
| -29% | -$2.01K | ﹤0.01% | 9184 |
|
|
2022
Q1 | $13K | Buy |
2,800
+2,600
| +1,300% | +$21.3K | ﹤0.01% | 8673 |
|
|
2021
Q4 | $2K | Sell |
200
-800
| -80% | -$15.9K | ﹤0.01% | 10030 |
|
|
2021
Q3 | $20K | Buy |
1,000
+300
| +43% | +$6.45K | ﹤0.01% | 8448 |
|
|
2021
Q2 | $11K | Buy |
700
+692
| +8,650% | +$13.2K | ﹤0.01% | 9046 |
|
|
2021
Q1 | $18K | Sell |
8
-5
| -38% | -$149 | ﹤0.01% | 7543 |
|
|
2020
Q4 | $31K | Buy |
13
+11
| +550% | +$175 | ﹤0.01% | 6636 |
|
|
2020
Q3 | $2K | Sell |
2
-6
| -75% | -$65 | ﹤0.01% | 7445 |
|
|
2020
Q2 | $8K | Sell |
8
-53
| -87% | -$477 | ﹤0.01% | 6764 |
|
|
2020
Q1 | $43K | Sell |
61
-18
| -23% | -$187 | ﹤0.01% | 5295 |
|
|
2019
Q4 | $105K | Buy |
79
+69
| +690% | +$983 | ﹤0.01% | 4467 |
|
|
2019
Q3 | $15K | Sell |
10
-29
| -74% | -$377 | ﹤0.01% | 6013 |
|
|
2019
Q2 | $51K | Sell |
39
-34
| -47% | -$464 | ﹤0.01% | 4849 |
|
|
2019
Q1 | $128K | Buy |
73
+4
| +6% | +$63 | ﹤0.01% | 4084 |
|
|
2018
Q4 | $79K | Buy |
69
+64
| +1,280% | +$774 | ﹤0.01% | 4079 |
|
|
2018
Q3 | $7K | Sell |
5
-87
| -95% | -$1.24K | ﹤0.01% | 6612 |
|
|
2018
Q2 | $139K | Buy |
+92
| New | +$1.56K | ﹤0.01% | 3901 |
|
Other funds holding PLSE
PCM
Simplex Trading's PLSE Position: Q2 2026 in Review
Simplex Trading opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 420 shares worth $11.6K. The stake represents ﹤0.01% of the portfolio and ranks #7565 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PLSE as recently as Q3 2025.
Simplex Trading first reported a position in PLSE in Q3 2017 and has held it in 23 quarters since. The position peaked at $419K in Q4 2023. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.
- Simplex Trading held 420 shares of Pulse Biosciences worth $11.6K as of Q2 2026.
- Pulse Biosciences was a new Simplex Trading position in Q2 2026.
- Pulse Biosciences made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7565 holding.
- Simplex Trading first reported a position in Pulse Biosciences in Q3 2017 and has held it in 23 quarters since.
- Simplex Trading's Pulse Biosciences position peaked at $419K in Q4 2023.
- 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.